iCoreConnect Inc

Aktienanalyse zu iCoreConnect Inc (ICCT)

$1.860

-0.322 (-17.33%)Zum Schluss

Loading chart…
High
2.287
Open
2.280
VWAP
1.98
Vol
1.69M
Mkt Cap
9.61M
Low
1.800
Amount
3.35M
EV/EBITDA, TTM
0.00

iCoreConnect Inc. is a cloud-based software and technology company. The Company is focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. The Company is primarily engaged in providing solutions to solve the healthcare business problems. iCoreConnect touts a platform of over 16 software-as-a-service (SaaS) enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States. It offers solutions for the dental, medical and business information technology (IT) sectors. The Company offers cloud-based SaaS offering under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims, iCoreHIPAA, iCoreAcademy and iCoreIT. iCoreRx is an e-prescribing solution to improve efficiency, resource utilization, and patient safety.

Bewertungskennzahlen

The current forward P/E ratio for iCoreConnect Inc (ICCT) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
15.84
Current EV/EBITDA
0.00
Überbewertet
54.25
Unterbewertet
-22.56

Forward P/S

Fair
5Y Average P/S
1.44
Current P/S
0.00
Überbewertet
4.93
Unterbewertet
-2.05

Event-Zeitleiste

2024-12-19 (ET)

07:38:43

iCoreConnect announces 1-for-20 reverse stock split

2024-11-25 (ET)

07:38:57

iCoreConnect announes expansion of partnership with MSDA

2024-11-21 (ET)

07:36:17

iCoreConnect reports Q3 revenue $2.788M vs $2M last year

2024-11-14 (ET)

07:50:52

iCoreConnect announces new endorsement agreement with NDDA

2024-10-09 (ET)

08:38:54

iCoreConnect announces new endorsement agreemenet with DSDS

News

ICCT FAQ — answered by Alphio AI

iCoreConnect Inc. is a cloud-based software and technology company. The Company is focused on increasing workflow productivity and practice profitability through its enterprise and healthcare workflow platform of applications and services. The Company is primarily engaged in providing solutions to solve the healthcare business problems. iCoreConnect touts a platform of over 16 software-as-a-service (SaaS) enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States. It offers solutions for the dental, medical and business information technology (IT) sectors. The Company offers cloud-based SaaS offering under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims, iCoreHIPAA, iCoreAcademy and iCoreIT. iCoreRx is an e-prescribing solution to improve efficiency, resource utilization, and patient safety. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten